Julia Schueler In vivo Tumorbiology Oncotest GmbH Biography Publications Institution JoVE Articles Julia Schueler has not added a biography. If you are Julia Schueler and would like to personalize this page please email our Author Liaison for assistance. Publications BEZ235 (PIK3/mTOR Inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells Translational Oncology. Jun, 2016 | Pubmed ID: 27267837 Capturing Complex Tumour Biology in Vitro: Histological and Molecular Characterisation of Precision Cut Slices Scientific Reports. 2015 | Pubmed ID: 26647838 Patient-derived Cell Models As Preclinical Tools for Genome-directed Targeted Therapy Oncotarget. Sep, 2015 | Pubmed ID: 26296973 Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(null) Mice Mimics Human Myeloma and Serves As a Valuable Tool for the Development of Anticancer Strategies PloS One. 2013 | Pubmed ID: 24223204 Human Vδ1 γδ T Cells Expanded from Peripheral Blood Exhibit Specific Cytotoxicity Against B-cell Chronic Lymphocytic Leukemia-derived Cells Cytotherapy. Jul, 2011 | Pubmed ID: 21314241 L'esaurimento delle cellule di topo da xenotrapianti tumorali umani migliora in modo significativo Analisi A valle delle cellule bersaglio David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Médecine
L'esaurimento delle cellule di topo da xenotrapianti tumorali umani migliora in modo significativo Analisi A valle delle cellule bersaglio David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Médecine